2023 expert speaker series

How to Rapidly Identify Refractory Psychosis Patients and What to Do About It

Presented by:

Kara Dempster, MD, MSC, FRCPC

Assistant Professor, Department of Psychiatry, Dalhousie University

Associate Clinical Director, Nova Scotia Early Psychosis Program

Halifax, NS

This initiative has been sponsored in part by Abbvie, Janssen, and Otsuka-Lundbeck Alliance, and Teva through an educational grant.

Personalizing the Pharmacotherapy Approach in First Episode Psychosis Based on Patient Need

Presented by:

Howard C. Margolese, MDCM, MSc, FRCPC

Associate Professor, Dept. of Psychiatry, McGill University

Director, PEPP-MUHC, First Episode Psychosis Program

Webinar Objectives:

Discuss medication treatment approach in first episode psychosis
Chose medication based on tolerability and address side effects.
Highlight importance of treating co-morbidities
Introduce shared decision-making concepts to improve therapeutic alliance and improve medication acceptance and adherence

This initiative has been sponsored in part by Abbvie, Janssen, and Otsuka-Lundbeck Alliance, and Teva through an educational grant.

CBT for Early Psychosis - Answering the Real Questions

Presented by:

Tania Lecomte, PhD
Professor, Department of Psychology

University of Montreal

Montreal, QC

Webinar Objectives:

After attending this course, participants should be better able to:

This initiative has been sponsored in part by Abbvie, Janssen, and Otsuka-Lundbeck Alliance, and Teva through an educational grant.